CLINICAL TRIALS PROFILE FOR VELETRI
✉ Email this page to a colleague
All Clinical Trials for VELETRI
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03081052 ↗ | Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes | Active, not recruiting | Duke University | Phase 4 | 2017-05-04 | 1. to conduct a clinical investigation to determine if inhaled epoprostenol (VeletriĀ®, iEPO) and inhaled nitric oxide (iNO) will have similar impact on outcomes in adult patients undergoing durable LVAD placement, heart transplantation, or lung transplantation 2. to conduct a cost-capture analysis on the expense each drug incurs per patient. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VELETRI
Condition Name
Clinical Trial Locations for VELETRI
Trials by Country
Clinical Trial Progress for VELETRI
Clinical Trial Phase
Clinical Trial Sponsors for VELETRI
Sponsor Name